Under the tradename of Chiralscreen™, Daicel is introducing a formate dehydrogenase which by protein engineering techniques has a high selectivity for NADPH regeneration. The development was done in collaboration with Prof. Koji ISHIHARA of Okayama University.

Daicel Exibition Information, JSBBA Meeting Sendai, March 27, 2013